Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0000899243-21-016935

Chief Technology Officer acquired 1,000,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Falconer Ester Chief Technology Officer 2021-03-19 Option exercise +1,000,000 $0.03 $34,300 1,000,000 D
Derivatives
Falconer Ester Chief Technology Officer 2021-03-19 Option exercise · Share Option (right to buy) −1,000,000 0 D
Loading xslF345X03/doc4.xml…